液体活检采血管市场基于(主要区域、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00019989
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

Blood Collection Tubes for Liquid Biopsy Market Growth | 2028

Buy Now

液体活检采血管市场规模预计将从 2021 年的 7903 万美元增至 2028 年的 2.5626 亿美元;预计 2021 年至 2028 年的复合年增长率18.3%。

液体活检是一种非侵入性手术活检替代方法,可让医生获得有关检测到的肿瘤的重要信息。在血液样本中检测到的癌症 DNA 痕迹可以揭示哪种治疗方法更适合特定患者。通过液体活检进行循环游离​​ DNA ( cfDNA ) 分析的可能性促成了许多专门测量技术的开发。在过去几年中,人们对液体活检工作流程的 (预) 分析条件的兴趣激增。

液体活检用采血管市场根据产品、材料、应用、最终用户和地域进行细分。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告提供了对市场的深入见解,强调了市场趋势、技术进步和市场动态等参数,以及对主要市场参与者的竞争格局的分析。     

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

液体活检采血管市场:

液体活检用采血管市场

  • 复合年增长率(2021 - 2028 年)
    18.3%
  • 2021 年市场规模
    7903 万美元
  • 2028 年市场规模
    2.5626 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • PreAnalytix有限公司 GmbH
  • Biocept 公司,Inc.
  • F.霍夫曼-拉罗氏有限公司HOFFMANN-LA ROCHE LTD
  • 斯特莱克
  • Norgen Biotek 公司
  • 精确科学公司
  • 格瑞纳股份公司
  • MagBio Genomics 公司
  • Zymo 研究公司

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • ccfDNA 管
  • cfRNA 管
  • CTC 管
  • gDNA 管
  • 细胞内 RNA 管
  • 其他的
材料
  • 玻璃和塑料
应用
  • 体外诊断
最终用户
  • 基因诊断实验室
  • 研发中心
  • 传统诊断中心
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场洞察

癌症患病率上升推动液体活检采血管市场增长

世界各地的卫生系统都见证着癌症患病率的大幅上升。根据世界卫生组织 (WHO) 的数据,癌症是全球第二大死亡原因。此外,国际癌症研究机构 (IARC) 指出,2020 年全球癌症负担达到 1930 万例,癌症死亡人数达到 996 万。根据世卫组织公布的数据,2019 年全球约有 960 万人死于癌症。此外,前列腺癌、肺癌、结直肠癌、肝癌和胃癌是男性中最常见的癌症类型,而乳腺癌、结直肠癌和宫颈癌在女性中更为常见。

根据美国国家癌症研究所发布的研究,2021年,美国癌症发病率可能达到190万。在美国,2021年预计将有约60万人死于癌症。此外,根据英国癌症研究中心2020年发布的数据,英国每年约有16万人死于癌症。2018年发布的Globocan报告称,全球共有911,014例乳腺癌病例和310,577例乳腺癌死亡病例, 其中中国和印度分别报告了367,900例和162,468例乳腺癌病例。

液体活检用于诊断非小细胞肺癌 (NSCLC) 和筛查,或作为结直肠癌、乳腺癌、胃肠道癌、前列腺癌和卵巢癌等其他类型癌症的伴随诊断。与传统癌症诊断方法相比,液体活检具有早期预后、降低成本、治疗监测、获得性耐药性、检测肿瘤异质性和患者舒适度等优势,因为它无需手术。因此,随着癌症患病率的上升,人们对液体活检的偏好也在增加。液体活检程序有助于组织尽早、准确地发现癌症,从而快速治疗癌症患者并提高他们的存活率。这一因素最终将在未来几年推动对用于收集液体活检程序样本的采血管的需求。

微创诊断测试需求增长显著促进液体活检采血管市场增长

越来越多的患者倾向于进行微创或非侵入性检测以进行诊断。液体活检可用于早期癌症和突变检测、治疗期间的肿瘤监测和复发监测。该技术采用非手术方法,收集血液样本进行检测。研究人员可以使用血液样本追踪实体肿瘤中的所有表观遗传和遗传变化。患者在液体活检过程中感染和失血的风险较小,临床医生可以轻松地多次进行这些测试。此外,患者更喜欢微创手术,因为此类手术中使用的先进仪器可以以更低的风险、更少的疼痛和最小的疤痕进行更精细和复杂的工作。此外,它还减少了诊断病情所需的成本和时间。  

由于可行性和处理时间方面的技术进步,液体活检最近引起了人们的极大兴趣,成为癌症患者组织活检的非侵入性替代方法。CTC、cfDNA、外泌体和微囊泡也可以在血液样本中检测到,这使得基于血液的液体活检越来越受欢迎。传统活检是一种高度侵入性的手术,外科医生会避免让患者面临风险。因此,对安全、非侵入性癌症诊断技术的需求日益增长,推动了液体活检采血管市场的发展。

产品洞察           

根据产品,全球液体活检采血管市场细分为 Ccf DNA 管、CfRNA 管、CTC 管、GDNA 管等。2021,Ccf DNA 管细分市场占据了最大的市场份额。预计同一细分市场将在 2021-2028 年期间实现最高的市场复合年增长率。ccfDNA 管用于收集、储存和运输静脉全血,以及稳定 DNA 以进行提取、血浆中的游离 DNA (ccfDNA) 和有核细胞部分的基因组 DNA (gDNA)。当无法在采集当天处理样本时,临床实验室可以使用 ccfDNA 管来稳定样本。

最终用户洞察

根据最终用户,液体活检采血管市场细分为基因诊断实验室、研发中心、传统诊断中心等。基因诊断实验室部分在 2021 年占据了最大的市场份额。预计在预测期内,该部分将进一步占据相当大的市场份额。

产品发布和并购是全球液体活检采血管市场参与者广泛采用的策略。以下列出了一些近期的关键市场发展:

2021 年 11 月,PreAnalytiX GmbH 推出了符合欧盟新 IVDR 要求的 QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD)。PAXgene Blood ccfDNA Tube (CE-IVD) 和试剂盒已通过验证,被确认为一种集成工作流程解决方案,可用于需要自动化解决方案的诊断实验室中标准化和可重复的 ccfDNA 处理。2021 年 2 月,Biocept, Inc. 宣布与 Protean BioDiagnostics Inc. 合作,研究 Biocept 的 Target SelectorTM 分子检测在 NSCLC 患者中获取 EGFR 状态的能力。

2020 年,随着 COVID-19 疫情的爆发,液体活检用采血管的需求下降。COVID-19 的影响前所未有,影响深远,据称对癌症患者的影响更为严重。为降低感染率而采取的限制措施极大地限制了接受癌症筛查、诊断和治疗的患者数量。此外,由于 COVID-19 患者住院率的上升,压力激增,导致许多医院和医疗部门(包括肿瘤诊所)重新调整治疗此类患者的计划。根据其中一项研究,全球许多诊断和治疗程序被取消或推迟,其中包括约 230 万例癌症手术。

液体活检采血管——市场细分

全球液体活检采血管市场根据产品、材料、应用和地域进行细分。根据产品,市场细分为 ccfDNA 管、cfRNA 管、CTC 管、gDNA 管、细胞内 RNA 管等。根据材料,液体活检采血管市场分为玻璃和塑料。根据应用,液体活检采血管市场进一步细分为体外诊断 (IVD)和研究。根据地域,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。

液体活检采血管市场报告范围

报告属性细节
2021 年市场规模7903万美元
2028 年市场规模2.5626亿美元
全球复合年增长率(2021 - 2028)18.3%
历史数据2019-2020
预测期2022-2028
涵盖的领域按产品
  • ccfDNA 管
  • cfRNA 管
  • CTC 管
  • gDNA 管
  • 细胞内 RNA 管
  • 其他的
按材质
  • 玻璃和塑料
按应用
  • 体外诊断
按最终用户
  • 基因诊断实验室
  • 研发中心
  • 传统诊断中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • PreAnalytix有限公司
  • Biocept 公司
  • F.霍夫曼-拉罗氏有限公司
  • 斯特莱克
  • Norgen Biotek 公司
  • 精确科学公司
  • 格瑞纳股份公司
  • MagBio Genomics 公司
  • Zymo 研究公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

公司简介

  • PreAnalytix有限公司
  • Biocept 公司
  • F.霍夫曼-拉罗氏有限公司
  • 斯特莱克
  • Norgen Biotek 公司
  • 精确科学公司
  • 格瑞纳股份公司
  • MagBio Genomics 公司
  • Zymo 研究公司
  • 使徒科学
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the most influencing segment growing in the blood collection tubes for liquid biopsy market report?

ccfDNA Tubes segment is growing in the blood collection tubes for liquid biopsy market.

What are the opportunities for new blood collection tubes for liquid biopsy market entrants?

Untapped Potential of Emerging Economies is likely to fuel the market growth in the coming years.

Which are the key players in the blood collection tubes for liquid biopsy market?

Key players in the market are PreAnalytix GmbH, Biocept,Inc., F. HOFFMANN-LA ROCHE LTD, STRECK, Norgen Biotek Corp, Exact Sciences Corporation, Greiner AG, MagBio Genomics, Inc., Zymo Research Corporation, Apostle Sciences among others.

What are the key trends in the blood collection tubes for liquid biopsy market?

Technological advancements in blood collection tubes for liquid biopsy is likely to act as a trend the market growth in the coming years.

What is blood collection tubes for liquid biopsy?

A liquid biopsy is a non-invasive, non-invasive alternative to surgical biopsies that allows doctors to learn a lot about a tumour by taking a blood sample. Cancer DNA traces in the blood can reveal which treatments are most likely to work for a given patient. The development of numerous specialised measurement techniques has resulted from the possibility of circulating cell-free DNA (cfDNA) analysis as a liquid biopsy. Over the last few years, there has been a surge in interest in the (pre-) analytical conditions of the liquid biopsy workflow.

What are the driving factors for the blood collection tubes for liquid biopsy market across the globe?

Key factors driving the growth of the market are the increase in prevalence of cancer worldwide and rising demand for minimally invasive diagnostic tests are driving the market's growth. However, the lack of skilled professionals leading to inaccurate blood collection tubes for liquid biopsy analysis is hampering the market growth.

The List of Companies - Blood Collection Tubes for Liquid Biopsy Market

  1. PreAnalytix GmbH
  2. Biocept,Inc.
  3. F. HOFFMANN-LA ROCHE LTD
  4. STRECK
  5. Norgen Biotek Corp
  6. Exact Sciences Corporation
  7. Greiner AG
  8. MagBio Genomics, Inc.
  9. Zymo Research Corporation
  10. Apostle Sciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports